- Home
- SEGG vs VYNE Comparison
SEGG vs VYNE Comparison
Compare SEGG & VYNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SEGG
- VYNE
- Stock Information
- Founded
- SEGG N/A
- VYNE 2003
- Country
- SEGG United States
- VYNE United States
- Employees
- SEGG 12
- VYNE N/A
- Industry
- SEGG Computer Software: Prepackaged Software
- VYNE Biotechnology: Pharmaceutical Preparations
- Sector
- SEGG Technology
- VYNE Health Care
- Exchange
- SEGG Nasdaq
- VYNE Nasdaq
- Market Cap
- SEGG 24.8M
- VYNE 24.3M
- IPO Year
- SEGG 2023
- VYNE 2018
- Fundamental
- Price
- SEGG $0.81
- VYNE $0.36
- Analyst Decision
- SEGG
- VYNE Buy
- Analyst Count
- SEGG 0
- VYNE 2
- Target Price
- SEGG N/A
- VYNE $8.00
- AVG Volume (30 Days)
- SEGG N/A
- VYNE 3.7M
- Earning Date
- SEGG N/A
- VYNE 08-18-2025
- Dividend Yield
- SEGG N/A
- VYNE N/A
- EPS Growth
- SEGG N/A
- VYNE N/A
- EPS
- SEGG N/A
- VYNE N/A
- Revenue
- SEGG N/A
- VYNE $605,000.00
- Revenue This Year
- SEGG N/A
- VYNE $42.51
- Revenue Next Year
- SEGG N/A
- VYNE N/A
- P/E Ratio
- SEGG N/A
- VYNE N/A
- Revenue Growth
- SEGG N/A
- VYNE 43.03
- 52 Week Low
- SEGG N/A
- VYNE $0.34
- 52 Week High
- SEGG N/A
- VYNE $4.30
- Technical
- Relative Strength Index (RSI)
- SEGG N/A
- VYNE 29.21
- Support Level
- SEGG N/A
- VYNE $0.35
- Resistance Level
- SEGG N/A
- VYNE $0.40
- Average True Range (ATR)
- SEGG 0.00
- VYNE 0.10
- MACD
- SEGG 0.00
- VYNE -0.08
- Stochastic Oscillator
- SEGG 0.00
- VYNE 1.74
About SEGG Lottery.com Inc. Common Stock
Lottery.com Inc is a provider of domestic and international lottery products and services. As an independent third-party lottery game service, the Company offers a platform that it developed and operates to enable the remote purchase of legally sanctioned lottery games in the U.S. and abroad. The Company's revenue-generating activities are focused on (i) offering the Platform via the Lottery.com app and its websites to users located in the U.S. and international jurisdictions where the sale of lottery games is legal and its services are enabled for the remote purchase of legally sanctioned lottery games; (ii) offering an internally developed, created and operated business-to-business application programming interface of the Platform to enable commercial partners in permitted U.S.
About VYNE VYNE Therapeutics Inc.
VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Its products include AMZEEQ, ZILXI, and FCD105.